Robert E. Gagnon - Net Worth and Insider Trading
Robert E. Gagnon Net Worth
The estimated net worth of Robert E. Gagnon is at least $3 Million dollars as of 2026-08-10. Robert E. Gagnon is the CFO of Opus Genetics Inc and owns about 584,375 shares of Opus Genetics Inc (IRD) stock worth over $2 Million. Robert E. Gagnon is the Vice President, Finance of Biogen Inc and owns about 3,999 shares of Biogen Inc (BIIB) stock worth over $828,313. Robert E. Gagnon is also the Director of Verastem Inc and owns about 41,678 shares of Verastem Inc (VSTM) stock worth over $282,994. Besides these, Robert E. Gagnon also holds Harvard Bioscience Inc (HBIO) . Details can be seen in Robert E. Gagnon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E. Gagnon has not made any transactions after 2026-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert E. Gagnon
Robert E. Gagnon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E. Gagnon owns 7 companies in total, including Verastem Inc (VSTM) , Harvard Bioscience Inc (HBIO) , and Clean Harbors Inc (CLH) among others .
Click here to see the complete history of Robert E. Gagnon’s form 4 insider trades.
Insider Ownership Summary of Robert E. Gagnon
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VSTM | Verastem Inc | 2025-12-16 | Chief Financial Officer |
| HBIO | Harvard Bioscience Inc | 2018-08-29 | director |
| CLH | Clean Harbors Inc | 2012-08-20 | EVP CFO and Treasurer |
| 2012-02-29 | Chief Acct Officer VP & Contol | ||
| 2024-01-08 | director | ||
| 2026-07-23 | Chief Financial Officer | ||
| 2026-03-18 | director |
Robert E. Gagnon Latest Holdings Summary
Robert E. Gagnon currently owns a total of 4 stocks. Among these stocks, Robert E. Gagnon owns 584,375 shares of Opus Genetics Inc (IRD) as of July 23, 2026, with a value of $2 Million and a weighting of 61.89%. Robert E. Gagnon owns 3,999 shares of Biogen Inc (BIIB) as of February 29, 2012, with a value of $828,313 and a weighting of 23.97%. Robert E. Gagnon also owns 41,678 shares of Verastem Inc (VSTM) as of December 16, 2025, with a value of $282,994 and a weighting of 8.19%. The other 1 stocks Harvard Bioscience Inc (HBIO) have a combined weighting of 5.96% among all his current holdings.
Latest Holdings of Robert E. Gagnon
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRD | Opus Genetics Inc | 2026-07-23 | 584,375 | 3.66 | 2,138,813 |
| BIIB | Biogen Inc | 2012-02-29 | 3,999 | 207.13 | 828,313 |
| VSTM | Verastem Inc | 2025-12-16 | 41,678 | 6.79 | 282,994 |
| HBIO | Harvard Bioscience Inc | 2018-08-29 | 32,117 | 6.41 | 205,870 |
Holding Weightings of Robert E. Gagnon
Robert E. Gagnon Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 2 transactions in Opus Genetics Inc (IRD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Opus Genetics Inc is the sale of 7,783 shares on July 23, 2026, which brought Robert E. Gagnon around $22,960.
According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 1,552 shares on February 29, 2012, which brought Robert E. Gagnon around $178,868.
According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 20 transactions in Verastem Inc (VSTM) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Verastem Inc is the sale of 283 shares on December 16, 2025, which brought Robert E. Gagnon around $2,587.
More details on Robert E. Gagnon's insider transactions can be found in the Insider Trading History of Robert E. Gagnon table.Insider Trading History of Robert E. Gagnon
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Robert E. Gagnon Trading Performance
GuruFocus tracks the stock performance after each of Robert E. Gagnon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E. Gagnon is 10.52%. GuruFocus also compares Robert E. Gagnon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E. Gagnon within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert E. Gagnon's insider trading performs compared to the benchmark.
Performance of Robert E. Gagnon
Robert E. Gagnon Ownership Network
Ownership Network List of Robert E. Gagnon
Ownership Network Relation of Robert E. Gagnon

Robert E. Gagnon Owned Company Details
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Robert E. Gagnon is the Chief Financial Officer of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Operating Officer Matthew Ros .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Robert E. Gagnon made 4 insider transaction in Verastem Inc (VSTM) with a net sale of 1,132. Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 145,568 shares made by Dan Paterson , a net sale of 24,659 shares made by Daniel Calkins , and a net sale of 2,366 shares made by Brian M Stuglik .
In summary, during the past 3 months, insiders sold 26,262 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 26,262 shares. During the past 18 months, 196,858 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,858 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
Robert E. Gagnon Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E. Gagnon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert E. Gagnon's mailing address is: Needham Ma 02494.